ANTI-ADRENOMEDULLIN (ADM) ANTIBODIES, ANTI-ADM ANTIBODY FRAGMENTS OR ANTI-ADM NON-IG SCAFFOLD FOR PREVENTING OR ALLEVIATING ORGAN DYSFUNCTION OR ORGAN FAILURE IN PATIENTS HAVING CHRONIC OR ACUTE DISEASE OR ACUTE CONDITION
PROBLEM TO BE SOLVED: To provide anti-adrenomedullin (ADM) antibodies, anti-ADM antibody fragments or anti-ADM non-ig scaffolds for preventing or alleviating organ dysfunction or organ failure for use in therapy of chronic or acute disease or acute condition of a patient.SOLUTION: In preferred embodiments, a subject matter of this disclosure is anti-adrenomedullin (ADM) antibodies, anti-ADM antibody fragments or anti-ADM non-Ig scaffold for preventing or alleviating kidney dysfunction or failure or liver dysfunction disorder or failure for use in therapy of chronic or acute disease or acute condition of a patient.SELECTED DRAWING: Figure 3j【課題】 本開示の対象は、患者の慢性若しくは急性疾患又は急性病態の治療法における使用に向けた、臓器機能障害又は臓器不全の予防又は軽減のための、抗アドレノメデュリン（ＡＤＭ）抗体、抗アドレノメデュリン抗体フラグメント又は抗ＡＤＭ非Ｉｇ足場である。【解決手段】好ましい実施形態において、本開示の対象は、患者の慢性若しくは急性疾患又は急性病態の治療法における使用に向けた、腎機能障害若しくは腎不全又は肝機能障害若しくは肝不全の予防又は軽減のための、抗ＡＤＭ抗体、抗アドレノメデュリン抗体フラグメント又は抗ＡＤＭ非Ｉｇ足場である。【選択図】 図３ｊ
